Skip to main content
Equibles

Dennis McGrath

CFO

PAVmed Inc. (PAVM)

CFO

Lucid Diagnostics Inc. (LUCD)

Equibles does not estimate personal net worth.

Get an email with a short summary when PAVmed Inc. publishes a filing, an earnings call transcript or a press release.

Get PAVM alerts

About Dennis McGrath

Dennis McGrath is recorded as CFO at PAVmed Inc. (PAVM) and CFO at Lucid Diagnostics Inc. (LUCD). The newest filing on record that lists Dennis McGrath as CFO at PAVmed Inc. (PAVM) is dated April 30, 2026. The proxy statement of Lucid Diagnostics Inc. reports total compensation of $750,750 for Dennis McGrath in fiscal 2025, including a base salary of $225,000. Disclosed compensation is on record for 7 fiscal years. Dennis McGrath has spoken on 40 earnings calls across 2 companies, most recently for PAVmed Inc. on August 14, 2026. Those appearances were for PAVmed Inc. (PAVM) and Lucid Diagnostics Inc. (LUCD). PAVmed Inc. is classified in the Medical Devices industry within the Healthcare sector. Lucid Diagnostics Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at PAVmed Inc. includes Lishan Aklog (CEO), Michael J. Glennon (Chairman and Board Member), Shaun M. O’Neil (COO) and 7 others.

Dennis McGrath on recent calls

“Our summary financial results for the second quarter were reported in our press release that has been distributed.”
CFO, PAVmed Inc. Q2 FY2026 Earnings Call ·
“Our summary financial results for the first quarter were reported in our press release, but it's been distributed.”
CFO, PAVmed Inc. Q1 FY2026 Earnings Call ·
“We had a glitch in the prerecorded and prepared remarks, but the transition was at the appropriate time, so I'll pick up from there. So the summary financial results for the first quarter were reported, our press release that had been distributed.”
CFO, Lucid Diagnostics Inc. Q1 FY2026 Earnings Call ·
“Our summary financial results for the fourth quarter and the year were reported in our press release that has been distributed.”
CFO, PAVmed Inc. Q4 FY2025 Earnings Call ·
“The financial results for the fourth quarter of the year were reported in our press release. The next three slides will emphasize a few key financial highlights from the fourth quarter, but I encourage you to consider these year marks in the context of the full disclosures covered in our annual report on Form 2.”
CFO, Lucid Diagnostics Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at PAVmed Inc.

Leadership on record at Lucid Diagnostics Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Lucid Diagnostics Inc. (LUCD) $225,000 $750,750
2024 PAVmed Inc. (PAVM) $663,000 $1,085,950
2024 Lucid Diagnostics Inc. (LUCD) $225,000 $637,000
2023 PAVmed Inc. (PAVM) $663,000 $673,500
2023 Lucid Diagnostics Inc. (LUCD) $225,000 $225,000
2022 PAVmed Inc. (PAVM) $653,625 $1,233,075
2022 Lucid Diagnostics Inc. (LUCD) — $394,200
2021 PAVmed Inc. (PAVM) $422,500 $8,621,860
2021 Lucid Diagnostics Inc. (LUCD) — $7,280,760
2020 PAVmed Inc. (PAVM) $345,000 $1,027,700
2020 Lucid Diagnostics Inc. (LUCD) — —
2019 PAVmed Inc. (PAVM) $345,000 $1,047,500

Recent activity

Show 28 earlier activities